'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
Đọc thêm tại NPR
at September 4, 2020 at 04:00PM
Health & Science
Thứ Sáu, 4 tháng 9, 2020
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét